Oxidized lipids block antigen cross-presentation by dendritic cells in cancer

Wei Cao, Rupal Ramakrishnan, Vladimir A. Tuyrin, Filippo Veglia, Thomas Condamine, Andrew Amoscato, Dariush Mohammadyani, Joseph J. Johnson, Lan Min Zhang, Judith Klein-Seetharaman, Esteban Celis, Valerian E. Kagan, Dmitry I. Gabrilovich

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Cross-presentation is one of the main features of dendritic cells (DCs), which is critically important for the development of spontaneous and therapy-inducible antitumor immune responses. Patients, at early stages of cancer, have normal presence of DCs. However, the difficulties in the development of antitumor responses in patients with low tumor burden raised the question of the mechanisms of DC dysfunction. In this study, we found that, in differentiated DCs, tumor-derived factors blocked the crosspresentation of exogenous Ags without inhibiting the Ag presentation of endogenous protein or peptides. This effect was caused by intracellular accumulation of different types of oxidized neutral lipids: triglycerides, cholesterol esters, and fatty acids. In contrast, the accumulation of nonoxidized lipids did not affect cross-presentation. Oxidized lipids blocked cross-presentation by reducing the expression of peptide-MHC class I complexes on the cell surface. Thus, this study suggests the novel role of oxidized lipids in the regulation of cross-presentation. The Journal of Immunology, 2014, 192: 2920-2931.

Original languageEnglish (US)
Pages (from-to)2920-2931
Number of pages12
JournalJournal of Immunology
Volume192
Issue number6
DOIs
StatePublished - Mar 15 2014

Fingerprint

Cross-Priming
Antigen Presentation
Dendritic Cells
Lipids
Neoplasms
Peptides
Cholesterol Esters
Allergy and Immunology
Tumor Burden
Triglycerides
Fatty Acids
Proteins

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Cao, W., Ramakrishnan, R., Tuyrin, V. A., Veglia, F., Condamine, T., Amoscato, A., ... Gabrilovich, D. I. (2014). Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. Journal of Immunology, 192(6), 2920-2931. https://doi.org/10.4049/jimmunol.1302801

Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. / Cao, Wei; Ramakrishnan, Rupal; Tuyrin, Vladimir A.; Veglia, Filippo; Condamine, Thomas; Amoscato, Andrew; Mohammadyani, Dariush; Johnson, Joseph J.; Zhang, Lan Min; Klein-Seetharaman, Judith; Celis, Esteban; Kagan, Valerian E.; Gabrilovich, Dmitry I.

In: Journal of Immunology, Vol. 192, No. 6, 15.03.2014, p. 2920-2931.

Research output: Contribution to journalArticle

Cao, W, Ramakrishnan, R, Tuyrin, VA, Veglia, F, Condamine, T, Amoscato, A, Mohammadyani, D, Johnson, JJ, Zhang, LM, Klein-Seetharaman, J, Celis, E, Kagan, VE & Gabrilovich, DI 2014, 'Oxidized lipids block antigen cross-presentation by dendritic cells in cancer', Journal of Immunology, vol. 192, no. 6, pp. 2920-2931. https://doi.org/10.4049/jimmunol.1302801
Cao W, Ramakrishnan R, Tuyrin VA, Veglia F, Condamine T, Amoscato A et al. Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. Journal of Immunology. 2014 Mar 15;192(6):2920-2931. https://doi.org/10.4049/jimmunol.1302801
Cao, Wei ; Ramakrishnan, Rupal ; Tuyrin, Vladimir A. ; Veglia, Filippo ; Condamine, Thomas ; Amoscato, Andrew ; Mohammadyani, Dariush ; Johnson, Joseph J. ; Zhang, Lan Min ; Klein-Seetharaman, Judith ; Celis, Esteban ; Kagan, Valerian E. ; Gabrilovich, Dmitry I. / Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. In: Journal of Immunology. 2014 ; Vol. 192, No. 6. pp. 2920-2931.
@article{7258c28f317e47deab91f71e0784bdc7,
title = "Oxidized lipids block antigen cross-presentation by dendritic cells in cancer",
abstract = "Cross-presentation is one of the main features of dendritic cells (DCs), which is critically important for the development of spontaneous and therapy-inducible antitumor immune responses. Patients, at early stages of cancer, have normal presence of DCs. However, the difficulties in the development of antitumor responses in patients with low tumor burden raised the question of the mechanisms of DC dysfunction. In this study, we found that, in differentiated DCs, tumor-derived factors blocked the crosspresentation of exogenous Ags without inhibiting the Ag presentation of endogenous protein or peptides. This effect was caused by intracellular accumulation of different types of oxidized neutral lipids: triglycerides, cholesterol esters, and fatty acids. In contrast, the accumulation of nonoxidized lipids did not affect cross-presentation. Oxidized lipids blocked cross-presentation by reducing the expression of peptide-MHC class I complexes on the cell surface. Thus, this study suggests the novel role of oxidized lipids in the regulation of cross-presentation. The Journal of Immunology, 2014, 192: 2920-2931.",
author = "Wei Cao and Rupal Ramakrishnan and Tuyrin, {Vladimir A.} and Filippo Veglia and Thomas Condamine and Andrew Amoscato and Dariush Mohammadyani and Johnson, {Joseph J.} and Zhang, {Lan Min} and Judith Klein-Seetharaman and Esteban Celis and Kagan, {Valerian E.} and Gabrilovich, {Dmitry I.}",
year = "2014",
month = "3",
day = "15",
doi = "10.4049/jimmunol.1302801",
language = "English (US)",
volume = "192",
pages = "2920--2931",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "6",

}

TY - JOUR

T1 - Oxidized lipids block antigen cross-presentation by dendritic cells in cancer

AU - Cao, Wei

AU - Ramakrishnan, Rupal

AU - Tuyrin, Vladimir A.

AU - Veglia, Filippo

AU - Condamine, Thomas

AU - Amoscato, Andrew

AU - Mohammadyani, Dariush

AU - Johnson, Joseph J.

AU - Zhang, Lan Min

AU - Klein-Seetharaman, Judith

AU - Celis, Esteban

AU - Kagan, Valerian E.

AU - Gabrilovich, Dmitry I.

PY - 2014/3/15

Y1 - 2014/3/15

N2 - Cross-presentation is one of the main features of dendritic cells (DCs), which is critically important for the development of spontaneous and therapy-inducible antitumor immune responses. Patients, at early stages of cancer, have normal presence of DCs. However, the difficulties in the development of antitumor responses in patients with low tumor burden raised the question of the mechanisms of DC dysfunction. In this study, we found that, in differentiated DCs, tumor-derived factors blocked the crosspresentation of exogenous Ags without inhibiting the Ag presentation of endogenous protein or peptides. This effect was caused by intracellular accumulation of different types of oxidized neutral lipids: triglycerides, cholesterol esters, and fatty acids. In contrast, the accumulation of nonoxidized lipids did not affect cross-presentation. Oxidized lipids blocked cross-presentation by reducing the expression of peptide-MHC class I complexes on the cell surface. Thus, this study suggests the novel role of oxidized lipids in the regulation of cross-presentation. The Journal of Immunology, 2014, 192: 2920-2931.

AB - Cross-presentation is one of the main features of dendritic cells (DCs), which is critically important for the development of spontaneous and therapy-inducible antitumor immune responses. Patients, at early stages of cancer, have normal presence of DCs. However, the difficulties in the development of antitumor responses in patients with low tumor burden raised the question of the mechanisms of DC dysfunction. In this study, we found that, in differentiated DCs, tumor-derived factors blocked the crosspresentation of exogenous Ags without inhibiting the Ag presentation of endogenous protein or peptides. This effect was caused by intracellular accumulation of different types of oxidized neutral lipids: triglycerides, cholesterol esters, and fatty acids. In contrast, the accumulation of nonoxidized lipids did not affect cross-presentation. Oxidized lipids blocked cross-presentation by reducing the expression of peptide-MHC class I complexes on the cell surface. Thus, this study suggests the novel role of oxidized lipids in the regulation of cross-presentation. The Journal of Immunology, 2014, 192: 2920-2931.

UR - http://www.scopus.com/inward/record.url?scp=84897506146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897506146&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1302801

DO - 10.4049/jimmunol.1302801

M3 - Article

C2 - 24554775

AN - SCOPUS:84897506146

VL - 192

SP - 2920

EP - 2931

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 6

ER -